Astec LifeSciences Limited — Board Meeting, 28-03-2025: Outcome of Board Meeting

The company has announced a board meeting outcome, declaring a dividend of ₹50 Cr for the financial year. Additionally, the board approved a strategic initiative to raise ₹200 Cr through a rights issue to fuel expansion plans. The consolidated financial results reflect a revenue increase of 15% year-on-year to ₹1,000 Cr, with a net profit of ₹150 Cr for the quarter. These decisions are expected to enhance shareholder value and support future growth initiatives.